A pathological complete response after nivolumab plus ...

A case report highlights the use of dual immune checkpoint inhibitors (nivolumab and ipilimumab) in treating a large, locally advanced metastatic colon cancer with deficient mismatch repair, achieving a pathological complete response. This suggests potential benefits of immunotherapy before colorectal surgery, especially for dMMR/MSI-H tumors.